Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

Biological therapy boosts the immune system to effectively fight melanoma.

A new topical method using peptides boosts hair growth effectively with less finasteride and fewer side effects.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Mesotherapy with stem cells showed promising hair growth results in some patients with hair loss, but more research is needed.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Maternal hypothyroidism harms skin development in rat offspring.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Tadalafil and Finasteride may help treat aggressive melanoma.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

A new finasteride treatment may quickly and effectively promote hair regrowth.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Combination therapy works best for female hair loss, increasing density and thickness.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.